loading...| Preferred Name |
dalteparin sodium |
|
| Synonyms |
Fragmin |
|
| Definitions |
The sodium salt of a low molecular weight, synthetic heparin. As an anticoagulant/antithrombotic agent, dalteparin binds to antithrombin and enhances the inhibition of Factor Xa. Compared to unfractionated heparins, the use of dalteparin is associated with lower incidences of osteoporosis and heparin-induced thrombocytopenia. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C75767" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C75767" NCI Thesaurus) |
|
| ID |
http://purl.bioontology.org/ontology/PDQ/CDR0000043290 |
|
| altLabel |
Fragmin ALFA 87-120 Depo-Heparin Fragmin V |
|
| Component of | ||
| cui |
C0282471 C0917726 C2699556 C2699555 C2713185 |
|
| Date last modified |
2017-12-12 |
|
| definition |
The sodium salt of a low molecular weight, synthetic heparin. As an anticoagulant/antithrombotic agent, dalteparin binds to antithrombin and enhances the inhibition of Factor Xa. Compared to unfractionated heparins, the use of dalteparin is associated with lower incidences of osteoporosis and heparin-induced thrombocytopenia. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C75767" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C75767" NCI Thesaurus) |
|
| Legacy PDQ ID |
7804 |
|
| LT |
TRD |
|
| NCI ID |
C75767 |
|
| notation |
CDR0000043290 |
|
| ORIG STY |
Drug/agent |
|
| prefLabel |
dalteparin sodium |
|
| tui |
T109 T121 |